Status:
COMPLETED
Validation of Capnodynamic Assessment of Mixed Venous Oxygen Saturation
Lead Sponsor:
Karolinska Institutet
Conditions:
Cardiac Output, Low
Cardiac Output, High
Eligibility:
All Genders
Up to 18 years
Brief Summary
Mixed venous saturation (SvO2) is an indicator of the balance between oxygen supply and demand in the body's tissues Recently, our research team published a paper describing the possibility to continu...
Detailed Description
Background: Mixed venous saturation (SvO2) is an indicator of the balance between oxygen supply and demand in the body's tissues The primary objective of the current study is thus to investigate the a...
Eligibility Criteria
Inclusion
- Patients undergoing percutaneous intervention of cardiac conditions such as closure of atrial septal defect, persistent ductus arteriosus, pulmonary artery stenosis and diagnostic catheterization after heart transplant.
- \-
Exclusion
- ongoing ECMO treatment or intracardiac shunts not subjected to intervention. Weight less than 3.5 kg. Single ventricle circulation.
- \-
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04885699
Start Date
June 1 2021
End Date
October 1 2023
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 171 64